HemaCare Corp. To Present At Phacilitate Cell & Gene Therapy World 2016

LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation, a leader in cell and tissue collection, processing and cell therapy solutions, today announced that Lou Juliano, Senior Vice President of Global Sales and Business Development, will present recent findings by HemaCare’s research group on the sustainability of freshly isolated leukopaks (apheresis-derived white blood cells) when cryopreserved and shipped around the world for use in cell therapy applications.

Back to news